List of accepted posters

Nr	Title / Authors
2	Comprehensive bioinformatic analysis of HIV-1 protease specificity Liwen You Halmstad University, Sweden
3	The role of recombination in HIV evolution Andreas Meyerhans et al Department of Virology, University of the Saarland
4	Molecular epidemiology of hepatitis C virus in the Valencia region (Spain) Fernando González-Candelas et al Evolutionary Genetics Unit, “Cavanilles” Institute for Biodiversity and Evolutionary Biology, University of Valencia
5	Genetic variability and relatedness of hepatitis C virus strains and their effects on liver fibrosis progression Xavier López-Labrador and Fernando Gonzalez-Candelas “Cavanilles” Institute for Biodiversity and Evolutionary Biology, University of Valencia, and Public Health Department, Generalitat Valenciana.
6	Virus dynamics: Basic and detailed models of influenza A virus replication in mammalian cells Udo Reichl Max-Planck-Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
7	Modelling in-vivo HIV evolutionary mutational pathways under AZT-3TC regimen through Markov Chains Mattia Prosperi Faculty of Computer Engineering - University of Roma TRE
8	The European hepatitis C virus data base Christophe Combet Institut de Biologie et Chimie des Protéines, Lyon France
9	Selection of potential Cytotoxic T lymphocyte epitopes conserved among related Orthopoxviruses using a Bioinformatic Appoach Sheila Tuyet Tang et al Center for Biological Sequence Analysis, Technical University of Denmark
10	Phylogeny of HIV-1 subtype B in Denmark year 2001-2003 Audelin, A. M Department of Life Sciences and Chemistry, Roskilde University Centre, Denmark.
11	Fold predictions of HIV-1 p1 RNA from therapy-naive and -experienced patients suggest contribution to drug resistance Jens Verheyen Institute for Virology, University of Cologne
12	Amino acid variations in HCV p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C Christoph Welsch Klinik für Innere Medizin II, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
13	Detection and analysis of drug resistance mutations: Bioinformatics challenges and solutions. Mahanandeeshwar Gattu Research & Development, GlaxoSmithkline, USA & UK
14	Expression of HCV genes by alphavirus replicon vectors – implications for HCV vaccine design Ekaterina Alekseeva et al Biomedical Research and Study Centre, University of Latvia
15	Structure based analyses of HIV PI-resistance Daniel Hoffmann and Oli Grober Bingen University of Applied Sciences, Bioinformatics Project Group
16	Modelling molecular evolution of influenza Richard A. Goldstein National Institute for Medical Research
17	viRgil: An integrated interdisciplinary European Network of Excellence Ralf Bartenschlager Department Molecular Virology, University Heidelberg, Germany
18	Characterization on the dynamics of disappearance of protease resistance mutations during treatment interruption MM Santoro at al University of Rome Tor Vergata, Rome
19	A cross-talk between cellular and viral proteins: functional inference by a comparative proteome approach Iris Bahir et al Hebrew University
20	Treatment history improves the accuracy of neural networks predicting virologic response to HIV therapy Dechao Wang HIV Resistance Response Database Initiative, London, UK
21	HLA profiles predict known and novel HIV-1 escape mutations at a population level K. Roomp et al MPII, Saarbruecken, Germany
22	Immunological and virological parameters improve genotypic prediction of HIV-1 coreceptor usage T. Sing Max Planck Institute for Informatics, Saarbrücken, Germany
23	Geno2pheno and the Arevir database: tools for determination of clinically relevant cut-offs and prediction of viral load change from HIV-1 genotype. Martin Däumer et al Institute of Virology, University of Cologne
24	Probabilistic modeling of genetic barriers enables reliable prediction of HAART outcome at below 15% error rate Martin Däumer Institute of Virology, University of Cologne, Germany
25	HIV-salvage therapy guided by genotypic resistance testing and the geno2pheno® interpretation system Mark Oette et al University of Cologne, Germany
26	Efficacy of first-line antiretroviral HIV-therapy guided by genotypic resistance testing and the geno2pheno® interpretation system Mark Oette et al University of Cologne, Germany
27	Building and analysing an integrative model of HIV-1 RNA alternative splicing A. Bockmayr et al DFG Research Center Matheon & FU Berlin, Germany
28	Susceptibility to saquinavir and atazanavir in highly protease inhibitor (PI) resistant HIV-1 is caused by lopinavir-induced drug resistance mutation L76V Hauke Walter et al Institute for Virology, Cologne, Germany
29	Towards molecular characterization of HIV-vif interaction with human Apobec-3G C. Cramer von Laue et al centre of advanced european studies and research, Bonn, Germany
30	Developing a web-accessible, quality-based, molecular, clinical and epidemiological Database for hepatitis B infection Jonathan Green et al Centre for Infections, Health Protection Agency, London, UK
31	Relation of 2D and 3D descriptors of HIV protease inhibitors to drug resistance F.Cordes et al Zuse Institut Berlin (ZIB)